Senate panel advances legislation capping private insurance insulin at $35

Bill co-sponsored by Collins to cap insulin prices advances

Maine passed a similar law in 2020 that affects about 21% of the insured population.

U.S. Sen. Tammy Baldwin: Baldwin’s Bipartisan Bill to Cap Insulin Costs at $35 Per Month for Millions Advances in the Senate

WASHINGTON, D.C. – Today, U.S. Senator Tammy Baldwin (D-WI) voted for and helped advance legislation to cap the out-of-pocket cost of insulin at $35 per month out of the Senate Health, Education, Labor and Pensions (HELP) Committee. The Improving Needed Safeguards for...

Bill to cap insulin costs moves forward in Congress

A bill that could cap insulin at $35 per month is moving forward in Congress.

Senate panel advances legislation capping private insurance insulin at $35

A Senate committee approved a bill to cap insulin costs at $35 for privately insured and uninsured Americans, though its path forward is uncertain.

Proposed insulin cap for all with insurance clears key U.S Senate panel

Following a decades-long fight, U.S. Sen. Jeanne Shaheen, D-N.H., has won an overwhelmingly bipartisan committee vote in her bid to cap insulin copayments at $35 per month for all health

$35 Commercial Insulin Bill Gets Advanced in Senate Health Panel

Legislation capping the cost of insulin in the commercial market at $35 moved one step closer to a full vote in the Senate after a powerful health committee advanced it Wednesday.